Thursday, March 19 10:30–11:30am
Cardiology Guidelines to Practice: 2026 Updates in HTN and Lipid Management
Thursday, March 19 2:30–4pm
Thursday, March 19 7:30–8:30am
AI - The Good, The Bad, and The Ugly (Navigating the New Reality of AI in Medicine)
Earn CME/CE credits in Washington, D.C.
Register NowFinancial Disclosures
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Information to come
- Peter Lin, MD, CCFP
- Speaker: Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eisai, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Moderna, Novo Nordisk, Pfizer, Sanofi
Other Disclosures
Pamela Kushner, MD, FAAFP (Reviewer): Speaker and Advisor for AstraZeneca, Boehringer Ingelheim, Corcept, GSK, Haleon, and Novo Nordisk; Speaker for Astellas, Bayer, Janssen, Lilly, and Phathom; Advisor for Abbott and Bausch/SALIX
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.